121 results on '"Aubin, Francois"'
Search Results
2. Vulvar Paget's disease: A population-based cancer registry descriptive study
3. Chimeric antigen receptor–modified T-cell therapy: Recent updates and challenges in autoimmune diseases
4. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series
5. Timing is essential: Humoral and cellular responses to SARS-CoV-2 vaccination in a cohort of patients with auto-immune diseases treated with rituximab
6. Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
7. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
8. Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell–Driven IL-17 Signature
9. Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma
10. Efficacy, safety and acceptability of a benzalkonium chloride spermicide cream in women aged 40 years and over needing contraception: A prospective multicentre study
11. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
12. Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation
13. Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
14. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
15. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
16. Le psoriasis du rhumatisme psoriasique
17. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
18. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy
19. Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma
20. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
21. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
22. Acceptabilité et efficacité des immunothérapies dans le traitement du mélanome
23. Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
24. Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas
25. « Discovering Pathology », un serious game dédié à la découverte de l’anatomopathologie pour les étudiants en médecine
26. Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria
27. Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome
28. Effets secondaires des inhibiteurs de checkpoint utilisés dans le traitement des mélanomes et d’autres cancers
29. Torsional balloon flight line oscillations: Comparison of modelling to flight data
30. Epi-O-07 - Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group
31. Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial
32. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study
33. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
34. Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
35. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
36. Impact of adjuvant radiation therapy on survival and recurrence in patients with stage I-III Merkel cell carcinoma: A retrospective study of 312 patients
37. Peripheral and Local Human Papillomavirus 16–Specific CD8+ T-Cell Expansions Characterize Erosive Oral Lichen Planus
38. Severe and refractory solar urticaria treated with intravenous immunoglobulins: A phase II multicenter study
39. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
40. Increased Levels of Circulating Microparticles Are Associated with Increased Procoagulant Activity in Patients with Cutaneous Malignant Melanoma
41. The complexity of adverse side-effects to biological agents
42. Pembrolizumab-induced myositis
43. Why Statistics Matter: Limited Inter-Rater Agreement Prevents Using the Psoriasis Area and Severity Index as a Unique Determinant of Therapeutic Decision in Psoriasis
44. Syndrome RS3PE induit par Pembrolizumab
45. Surveillance dermatologique d’un patient traité par les molécules ciblant le TNF alpha
46. Genital human Papillomavirus infection in patients with autoimmune inflammatory diseases
47. Infection génitale à papillomavirus humain au cours des maladies auto-inflammatoires et/ou auto-immunes
48. RS3PE syndrome induced by Pembrolizumab
49. Rheumatoid neutrophilic dermatitis
50. Onset or exacerbation of cutaneous psoriasis during TNFα antagonist therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.